Biogen Inc BIIB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:55 PM EST
234.06quote price arrow down-1.68 (-0.71%)
Volume
654,645
52 week range
228.68 - 468.55
Loading...
  • Open236.98
  • Day High239.58
  • Day Low233.46
  • Prev Close235.74
  • 52 Week High468.55
  • 52 Week High Date06/07/21
  • 52 Week Low228.68
  • 52 Week Low Date11/30/21

Key Stats

  • Market Cap34.882B
  • Shares Out149.03M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-4.22

KEY STATS

  • Open236.98
  • Day High239.58
  • Day Low233.46
  • Prev Close235.74
  • 52 Week High468.55
  • 52 Week High Date06/07/21
  • 52 Week Low228.68
  • 52 Week Low Date11/30/21
  • Market Cap34.882B
  • Shares Out149.03M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-4.22

RATIOS/PROFITABILITY

  • EPS (TTM)10.22
  • P/E (TTM)22.90
  • Fwd P/E (NTM)13.23
  • EBITDA (TTM)3.574B
  • ROE (TTM)17.39%
  • Revenue (TTM)11.698B
  • Gross Margin (TTM)83.95%
  • Net Margin (TTM)21.12%
  • Debt To Equity (MRQ)67.61%

EVENTS

  • Earnings Date02/01/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has...
Stelios Papadopoulos Ph.D.
Non-Executive Chairman
Michel Vounatsos
Chief Executive Officer
Michael McDonnell
Chief Financial Officer
Susan Alexander Esq., J.D.
Executive Vice President
Alphonse Galdes
Executive Vice President
Address
225 Binney St
Cambridge, MA
02142-1031
United States

Top Peers

SYMBOLLASTCHG%CHG
REGN
Regeneron Pharmaceuticals Inc
636.70+0.17+0.03%
BNTX
BioNTech SE
345.80-5.94-1.69%
SYNH
Syneos Health Inc
98.42+1.26+1.30%
ILMN
Illumina Inc
361.21-4.12-1.13%
CRL
Charles River Laboratories International Inc
368.33+2.46+0.67%